Burning Rock Schedules First Quarter of 2024 Earnings Release on
May 29, 2024
GUANGZHOU, China, May 23, 2024-Burning Rock Biotech
Limited (NASDAQ: BNR and LSE: BNR, the "Company" or "Burning
Rock"), a company focused on the application of next generation
sequencing (NGS) technology in the field of precision oncology,
today announced that it plans to release its unaudited financial
results for the first quarter of 2024 before the U.S. market opens
on May 29, 2024. Following the release, company management will
host a conference call at 8:00 a.m. ET (8:00 p.m. Hong Kong time)
on the same day to discuss its financial results for the first
quarter of 2024.
Please register in advance of the conference using
the link provided below and dial in 15 minutes prior to the call,
using participant dial-in numbers and unique registrant ID which
would be provided upon registering.
PRE-REGISTER LINK:
https://register.vevent.com/register/BIbdb6210ab73d4bb7b25e3ffbdc206d07.
Additionally, a live and archived webcast of the
conference call will also be available on the company's investor
relations website at http://ir.brbiotech.com or through
link
https://edge.media-server.com/mmc/p/ovj2q2n6.
A replay of the webcast will be available for 12
months via the same link above.
Please visit the Company's investor relations website
at https://ir.brbiotech.com/news-events/news-releases on May 29,
2024 to view the earnings release prior to the conference call.
About Burning
Rock
Burning Rock Biotech Limited
(NASDAQ: BNR and LSE: BNR), whose mission is to Guard Life via
Science, focuses on the application of next generation sequencing
(NGS) technology in the field of precision oncology. Its business
consists of i) NGS-based therapy selection testing for late-stage
cancer patients, and ii) NGS-based cancer early detection, which
has moved beyond proof-of-concept R&D into the clinical
validation stage.
For more information about Burning
Rock, please visit:
www.brbiotech.com.
Safe Harbor
Statement
This press release contains
forward-looking statements. These statements constitute
"forward-looking" statements within the meaning of Section 21E of
the Securities Exchange Act of 1934, as amended, and as defined in
the U.S. Private Securities Litigation Reform Act of 1995. These
forward-looking statements can be identified by terminology such as
"will," "expects," "anticipates," "future," "intends," "plans,"
"believes," "estimates," "target," "confident" and similar
statements. Burning Rock may also make written or oral
forward-looking statements in its periodic reports to the SEC, in
its annual report to shareholders, in press releases and other
written materials and in oral statements made by its officers,
directors or employees to third parties. Statements that are not
historical facts, including statements about Burning Rock's beliefs
and expectations, are forward-looking statements. Such statements
are based upon management's current expectations and current market
and operating conditions, and relate to events that involve known
or unknown risks, uncertainties and other factors, all of which are
difficult to predict and many of which are beyond Burning Rock's
control. Forward-looking statements involve risks, uncertainties
and other factors that could cause actual results to differ
materially from those contained in any such statements. All
information provided in this press release is as of the date of
this press release, and Burning Rock does not undertake any
obligation to update any forward-looking statement as a result of
new information, future events or otherwise, except as required
under applicable law.
Contact: IR@brbiotech.com
